Vaginal estradiol use and the risk for cardiovascular mortality.
about
New evidence for cardiac benefit of postmenopausal hormone therapy.A theory of eu-estrogenemia: a unifying concept.Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
P2860
Vaginal estradiol use and the risk for cardiovascular mortality.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Vaginal estradiol use and the risk for cardiovascular mortality.
@en
Vaginal estradiol use and the risk for cardiovascular mortality.
@nl
type
label
Vaginal estradiol use and the risk for cardiovascular mortality.
@en
Vaginal estradiol use and the risk for cardiovascular mortality.
@nl
prefLabel
Vaginal estradiol use and the risk for cardiovascular mortality.
@en
Vaginal estradiol use and the risk for cardiovascular mortality.
@nl
P2093
P2860
P50
P356
P1433
P1476
Vaginal estradiol use and the risk for cardiovascular mortality.
@en
P2093
Heli Lyytinen
Pasi Korhonen
Pauliina Tuomikoski
Pia Vattulainen
P2860
P304
P356
10.1093/HUMREP/DEW014
P407
P577
2016-02-13T00:00:00Z